Read this before using this platform. lichensclerosus.ai provides AI-generated educational content about lichen sclerosus biology. It is not a medical service. The operator is not a licensed physician or healthcare professional. Nothing on this platform constitutes medical advice, diagnosis, or treatment. By using this platform you accept these terms in full.
By accessing or using lichensclerosus.ai (the "Platform"), you agree to be bound by these Terms of Service ("Terms"), our Privacy Policy, and any additional terms applicable to specific features. If you do not agree to these Terms, do not use the Platform.
These Terms constitute a legally binding agreement between you and Alessandro Cuggiani ("Operator," "we," "us"), an individual based in Tbilisi, Georgia.
If you are using the Platform on behalf of an organization, you represent that you have authority to bind that organization to these Terms.
This section is the most important part of these Terms. Read it carefully.
lichensclerosus.ai is an educational information platform. It is not a healthcare provider, medical practice, telemedicine service, clinical decision support tool, or medical device of any kind.
Alessandro Cuggiani, the operator of this Platform, is an independent researcher and patient advocate. He is not a physician, dermatologist, gynecologist, nurse practitioner, pharmacist, psychologist, or any other licensed healthcare professional. He is not registered with any medical professional body, including but not limited to:
All content generated by this Platform — including AI responses, tool outputs, symptom analyses, treatment guides, flare protocols, ingredient assessments, and check-in summaries — is strictly educational and informational. It describes biological mechanisms and published research patterns about lichen sclerosus.
Nothing on this Platform:
You acknowledge that:
Il presente servizio non costituisce esercizio della professione medica ai sensi dell'art. 3 del Regio Decreto 31 agosto 1933 n. 1592 e successive modificazioni, né ai sensi di alcuna normativa vigente in materia di professioni sanitarie regolamentate in Italia.
In particular, this Platform does not provide:
The content provided by this Platform falls within the legally recognized category of health information ("informazione sanitaria") — the communication of scientific and biological knowledge in the field of lichen sclerosus, based on published peer-reviewed literature. This activity is lawfully exercised by non-licensed individuals and is explicitly distinguished from the reserved practice of medicine under Italian law and the jurisprudence of the Italian Supreme Court (Corte di Cassazione).
Italian users acknowledge this distinction and agree that their use of this Platform is limited to accessing educational information and does not constitute the receipt of medical care or professional health consultations reserved to licensed professionals under Italian law.
Gli utenti italiani riconoscono che l'utilizzo di questa piattaforma è limitato all'accesso a informazioni educative e non costituisce ricezione di assistenza medica o consulenza sanitaria professionale riservata a professionisti abilitati ai sensi della normativa italiana vigente.
In compliance with applicable AI transparency requirements — including Regulation (EU) 2024/1689 (EU AI Act), and US state disclosure laws (Utah AI Policy Act, Texas TRAIGA, California AB 489) — we make the following disclosures:
lichensclerosus.ai provides the following AI-powered educational tools:
All tools are educational. None constitute clinical services, diagnosis, or prescribed treatment.
You must be at least 18 years old to use this Platform. If you are between 13 and 17, you may use the Platform only with the explicit consent and supervision of a parent or legal guardian who accepts these Terms on your behalf. Users under 13 may not use this Platform.
This Platform does not require account creation. An anonymous UUID is generated automatically on first visit. If you choose to provide your email address, you create a limited profile governed by our Privacy Policy. You are responsible for maintaining the confidentiality of any access codes or credentials associated with your use.
A free tier is available providing limited daily access: 5 tool analyses and 10 chat messages per day per device. No payment or account is required.
Unlimited access is available via a paid subscription ($34/month or $297/year) processed through Gumroad. By subscribing, you agree to Gumroad's Terms of Service. We do not process payment information directly.
Upon purchase, Gumroad provides a license key that activates unlimited access. This key is personal and non-transferable. Sharing your license key with others is a violation of these Terms.
Subscription fees are non-refundable except where required by law, or at our sole discretion in exceptional circumstances. EU consumers have a 14-day right of withdrawal under Directive 2011/83/EU, which begins on the date of purchase. This right may be waived if digital content is provided immediately upon purchase with explicit prior consent.
You may cancel your subscription at any time through Gumroad. Cancellation takes effect at the end of the current billing period. Access will revert to the free tier. No partial refunds are provided for unused subscription periods.
We reserve the right to revoke a license key without refund in the event of: (a) fraudulent payment; (b) sharing of the license key; (c) use of the Platform in violation of these Terms; or (d) chargebacks or disputed payments.
You agree not to use the Platform to:
We reserve the right to terminate access for any user who violates these provisions.
All content on this Platform — including the biological framework, system prompts, tool design, user interface, and editorial content — is the intellectual property of Alessandro Cuggiani and is protected by copyright law.
The AI-generated responses produced in response to your queries are provided to you for personal, non-commercial use only. You may not reproduce, distribute, or republish AI-generated content from this Platform at scale or for commercial purposes without written permission.
The framework and content of this Platform is based on the book Lichen Sclerosus Decoded © 2026 Alessandro Cuggiani. All rights reserved.
Data you submit to the Platform (symptoms, check-in entries, INCI lists) remains your data. When you contribute to the community product database, you grant us a non-exclusive, royalty-free license to use that contribution in anonymized, aggregated form for the benefit of all users.
TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, THE PLATFORM IS PROVIDED "AS IS" AND "AS AVAILABLE" WITHOUT WARRANTIES OF ANY KIND, EXPRESS OR IMPLIED, INCLUDING BUT NOT LIMITED TO WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, ACCURACY, NON-INFRINGEMENT, OR UNINTERRUPTED AVAILABILITY.
We do not warrant that:
Health outcomes depend on individual biological factors, adherence to professional medical care, and many variables entirely outside our control. We make no representation that use of this Platform will improve, maintain, or have any effect on your health condition.
TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, IN NO EVENT SHALL ALESSANDRO CUGGIANI, HIS AFFILIATES, LICENSORS, OR SERVICE PROVIDERS BE LIABLE FOR ANY:
These limitations apply regardless of the legal theory under which the claim is brought and even if we have been advised of the possibility of such damages.
Ai sensi del Codice del Consumo italiano (D.Lgs. 206/2005) e della normativa europea a tutela dei consumatori, le limitazioni di responsabilità di cui sopra si applicano nei limiti consentiti dalla legge italiana. I diritti inderogabili dei consumatori ai sensi del diritto italiano ed europeo non sono pregiudicati da queste clausole.
Under Italian consumer protection law (D.Lgs. 206/2005) and applicable EU directives, mandatory consumer rights are not affected by the above limitations.
You agree to indemnify and hold harmless Alessandro Cuggiani, his affiliates, and service providers from and against any claims, liabilities, damages, losses, and expenses — including reasonable legal fees — arising from: (a) your use of the Platform in violation of these Terms; (b) your reliance on Platform content to make health or medical decisions; (c) your violation of any applicable law or regulation; or (d) your infringement of any third-party rights.
We may suspend or terminate your access to the Platform at any time, with or without notice, for violation of these Terms, fraudulent activity, or for any other reason at our discretion. Upon termination, your right to use the Platform ceases immediately.
You may stop using the Platform at any time. Provisions of these Terms that by their nature should survive termination will do so, including Sections 2, 3, 9, 10, 11, and 12.
These Terms are governed by and construed in accordance with the laws of the State of Georgia, USA (selected as governing law for international digital commerce purposes; this choice does not imply physical presence, tax residency, or business registration in Georgia, USA), without regard to conflict of law principles.
Any dispute arising from these Terms or use of the Platform will first be subject to good-faith negotiation. If unresolved within 30 days, disputes will be submitted to binding arbitration administered under the rules of the American Arbitration Association, conducted in English (remote arbitration available). You waive the right to participate in class action proceedings.
Notwithstanding the above governing law clause, EU consumers retain all mandatory rights afforded to them under applicable EU and member state consumer protection law, regardless of which law governs the contract.
In particular, Italian consumers retain the right to bring claims before the competent Italian courts under Regulation (EU) No 1215/2012 (Brussels I Recast) and may use the EU Online Dispute Resolution platform at ec.europa.eu/consumers/odr.
Gli utenti italiani possono anche rivolgersi al Garante per la protezione dei dati personali (garanteprivacy.it) per questioni relative alla privacy.
Ai sensi del Regolamento (UE) n. 1215/2012 e del Codice del Consumo italiano, i consumatori italiani conservano il diritto di adire i tribunali competenti in Italia e di avvalersi dei meccanismi di risoluzione alternativa delle controversie previsti dalla normativa europea e italiana.
If you are a consumer resident in the EU or Italy, the following additional provisions apply:
Under EU Directive 2011/83/EU (Consumer Rights Directive), implemented in Italy by D.Lgs. 21/2014, EU consumers have the right to withdraw from a digital service contract within 14 days of purchase without giving any reason. To exercise this right, contact us at [email protected] before the 14-day period expires.
Note: if you request immediate access to digital content upon purchase and explicitly acknowledge that this waives your right of withdrawal, the 14-day right may not apply. Gumroad's checkout process may include such an acknowledgment.
Digital content provided under these Terms must conform to what is described. If the Platform materially fails to provide the described functionality, EU consumers may request remedy, price reduction, or contract termination under applicable EU digital content rules.
Any term in these Terms that would be considered unfair or abusive under the Italian Codice del Consumo (D.Lgs. 206/2005, Art. 33-37) or Directive 93/13/EEC is null and void as to Italian and EU consumers and shall not be applied.
These Terms are written in English. Italian users may request a courtesy translation by contacting [email protected]. In case of any conflict between English and Italian versions, the English version prevails unless applicable Italian mandatory law requires otherwise.
We may update these Terms at any time. When we make material changes, we will update the "Last updated" date at the top of this page. For changes that materially affect your rights or obligations, we will notify opted-in users by email at least 14 days before the changes take effect.
Continued use of the Platform after the effective date of updated Terms constitutes acceptance of those Terms. If you do not agree to the updated Terms, you must stop using the Platform.
For questions about these Terms, to exercise your rights, or to report a violation:
Email: [email protected]
Operator: Alessandro Cuggiani, Tbilisi, Georgia
Response time: Within 5 business days for general inquiries; within 30 days for formal legal requests
EU/EEA consumers may also use the EU Online Dispute Resolution platform: ec.europa.eu/consumers/odr
Our email address for ODR purposes is: [email protected]